SC 13G | 2019-02-14 | PERCEPTIVE ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 12,241,305 | 9.9% | EDGAR |
SC 13G | 2019-02-14 | ACUTA CAPITAL PARTNERS, LLC | IOVANCE BIOTHERAPEUTICS, INC. | 3,019,201 | 2.5% | EDGAR |
SC 13G/A | 2019-02-13 | Broadfin Capital, LLC | IOVANCE BIOTHERAPEUTICS, INC. | 5,951,153 | 4.8% | EDGAR |
SC 13G/A | 2019-02-13 | ORBIMED ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 1,337,800 | 1.1% | EDGAR |
SC 13G/A | 2019-02-04 | BlackRock Inc. | IOVANCE BIOTHERAPEUTICS, INC. | 8,780,191 | 7.1% | EDGAR |
SC 13G/A | 2019-01-28 | FRANKLIN RESOURCES INC | IOVANCE BIOTHERAPEUTICS, INC. | 8,283,464 | 6.7% | EDGAR |
SC 13D/A | 2018-12-07 | Quogue Capital LLC | IOVANCE BIOTHERAPEUTICS, INC. | 9,000,000 | 7.2% | EDGAR |
SC 13G/A | 2018-02-14 | PERCEPTIVE ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 3,091,903 | 4.3% | EDGAR |
SC 13G | 2018-02-14 | ACUTA CAPITAL PARTNERS, LLC | IOVANCE BIOTHERAPEUTICS, INC. | 3,903,000 | 5.4% | EDGAR |
SC 13G/A | 2018-02-13 | FMR LLC | IOVANCE BIOTHERAPEUTICS, INC. | 1,798,028 | 2.5% | EDGAR |
SC 13G/A | 2018-02-13 | ORBIMED ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 3,246,226 | 4.5% | EDGAR |
SC 13G | 2018-02-13 | Broadfin Capital, LLC | IOVANCE BIOTHERAPEUTICS, INC. | 5,091,160 | 6.8% | EDGAR |
SC 13G/A | 2018-02-12 | venBio Select Advisor LLC | IOVANCE BIOTHERAPEUTICS, INC. | 5,253,450 | 7.2% | EDGAR |
SC 13G/A | 2018-02-07 | FRANKLIN RESOURCES INC | IOVANCE BIOTHERAPEUTICS, INC. | 4,979,466 | 6.9% | EDGAR |
SC 13G | 2018-01-25 | BlackRock Inc. | IOVANCE BIOTHERAPEUTICS, INC. | 4,864,841 | 6.7% | EDGAR |
SC 13G/A | 2017-08-03 | ACUTA CAPITAL PARTNERS, LLC | IOVANCE BIOTHERAPEUTICS, INC. | 3,959,944 | 6.4% | EDGAR |
SC 13G/A | 2017-05-09 | BlackRock Inc. | Lion Biotechnologies, Inc. | 6,309,870 | 10.1% | EDGAR |
SC 13G/A | 2017-02-16 | ACUTA CAPITAL PARTNERS, LLC | Lion Biotechnologies, Inc. | 3,809,944 | 6.1% | EDGAR |
SC 13G/A | 2017-02-14 | FMR LLC | Lion Biotechnologies, Inc. | 4,474,312 | 7.2% | EDGAR |
SC 13G/A | 2017-02-14 | PERCEPTIVE ADVISORS LLC | Lion Biotechnologies, Inc. | 3,567,553 | 5.7% | EDGAR |